A molecular biologist seeking EB-1A extraordinary ability classification. Although she met two criteria (judging and scholarly articles), she failed the third required criterion (original contributions of major significance), as evidence did not establish her research had widespread impact on the field.

Immunology and food allergy researcher petitioner met two of three required initial criteria (judging and scholarly articles). AAO dismissed appeal, finding petitioner failed original contributions criterion; highly-cited publications alone insufficient without evidence of major field significance and lacking national or international acclaim.

An executive and consultant in finance and accounting sought EB-1A extraordinary ability classification. She met two of four claimed criteria but the AAO found she lacked the requisite sustained national or international acclaim and had not risen to the very top of her field.

Postdoctoral biomedical researcher studying glioblastoma treatment claimed extraordinary ability through publications, peer review, and citations. AAO upheld meeting two criteria (judging, scholarly articles) but rejected major contributions criterion because evidence showed significant work without demonstrating major significance to field. Final merits finding: not at top of field.